0001439222-21-000003.txt : 20210212
0001439222-21-000003.hdr.sgml : 20210212
20210212162202
ACCESSION NUMBER: 0001439222-21-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210210
FILED AS OF DATE: 20210212
DATE AS OF CHANGE: 20210212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alenson Carman
CENTRAL INDEX KEY: 0001688865
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 21627848
MAIL ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001439222
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-8600
MAIL ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AGIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20080703
4
1
wf-form4_161316487303183.xml
FORM 4
X0306
4
2021-02-10
0
0001439222
AGIOS PHARMACEUTICALS, INC.
AGIO
0001688865
Alenson Carman
C/O AGIOS PHARMACEUTICALS INC.
88 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Principal Accounting Officer
Restricted stock units
2021-02-10
4
A
0
5922
0
A
Common stock
5922.0
5922
D
Stock option (right to buy)
56.68
2021-02-10
4
A
0
2961
0
A
2031-02-10
Common stock
2961.0
2961
D
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.
This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.
/s/ William Cook as attorney-in-fact for Carman Alenson
2021-02-12